CNSY · Cerenome Inc
United States · RS rating 3 · As of 2026-10-14
| Price | 1.69 USD |
|---|---|
| 1-day change | -2.9% |
| RS rating (overall / 1M / 3M / 12M) | 3 / 11 / 4 / 3 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 18 / 3 / 30 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -24.8% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +90.6% |
| Market cap (USD) | $26.4M |